Jun 01, 2023 / NTS GMT
Philip Toleikis - Sernova Corp. - President & CEO
Thanks very much for the opportunity to speak today. So Sernova is a publicly traded company. We are listed on the TSX up in Canada, on the OTCQB under SEOVF in the United States. And we have aspirations for Nasdaq at the right time. And we're also listed on the Xetra under PSH. And we are a clinical-stage company. These are our forward-looking statements.
So what is Sernova doing? So we are a cell therapeutic company and we're looking at treating and finding a functional cure for lifelong conditions where patients are having to take injections of medications on a daily basis. And we have what we call our Cell Pouch System and this provides the potential for a functional cure for these chronic diseases.
The Cell Pouch itself is an implantable device, and we'll talk about that in a few minutes. And this is for the placement of immune-protected therapeutic cells. And what is really important about our device, and devices in general, is that if you want to have a device that can have therapeutic cells, you have to make sure that there's no
Sernova Corp Cell & Gene Meeting on the Med 2023 Transcript
Feb 14, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers